Display options
Cite
Keegan PM, Surapaneni S, Platt MO. Sickle cell disease activates peripheral blood mononuclear cells to induce cathepsins k and v activity in endothelial cells. Anemia. 2012;2012:201781doi: 10.1155/2012/201781.
Keegan, P. M., Surapaneni, S., & Platt, M. O. (2012). Sickle cell disease activates peripheral blood mononuclear cells to induce cathepsins k and v activity in endothelial cells. Anemia, 2012201781. https://doi.org/10.1155/2012/201781
Keegan, Philip M, et al. "Sickle cell disease activates peripheral blood mononuclear cells to induce cathepsins k and v activity in endothelial cells." Anemia vol. 2012 (2012): 201781. doi: https://doi.org/10.1155/2012/201781
Keegan PM, Surapaneni S, Platt MO. Sickle cell disease activates peripheral blood mononuclear cells to induce cathepsins k and v activity in endothelial cells. Anemia. 2012;2012:201781. doi: 10.1155/2012/201781. Epub 2012 Apr 09. PMID: 22550569; PMCID: PMC3328887.
Copy Download .nbib Format: NLM
Share it on

Anemia. 2012;2012:201781. doi: 10.1155/2012/201781. Epub 2012 Apr 09.

Sickle cell disease activates peripheral blood mononuclear cells to induce cathepsins k and v activity in endothelial cells.

Anemia

Philip M Keegan, Sindhuja Surapaneni, Manu O Platt

Affiliations

  1. Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA.

PMID: 22550569 PMCID: PMC3328887 DOI: 10.1155/2012/201781

Abstract

Sickle cell disease is a genetic disease that increases systemic inflammation as well as the risk of pediatric strokes, but links between sickle-induced inflammation and arterial remodeling are not clear. Cathepsins are powerful elastases and collagenases secreted by endothelial cells and monocyte-derived macrophages in atherosclerosis, but their involvement in sickle cell disease has not been studied. Here, we investigated how tumor necrosis alpha (TNFα) and circulating mononuclear cell adhesion to human aortic endothelial cells (ECs) increase active cathepsins K and V as a model of inflammation occurring in the arterial wall. ECs were stimulated with TNFα and cultured with peripheral blood mononuclear cells (PBMCs) from persons homozygous for sickle (SS) or normal (AA) hemoglobin. TNFα was necessary to induce cathepsin K activity, but either PBMC binding or TNFα increased cathepsin V activity. SS PBMCs were unique; they induced cathepsin K in ECs without exogenous TNFα (n = 4, P < 0.05). Inhibition of c-Jun N-terminal kinase (JNK) significantly reduced cathepsins K and V activation by 60% and 51%, respectively. Together, the inflammation and activated circulating mononuclear cells upregulate cathepsin activity through JNK signaling, identifying new pharmaceutical targets to block the accelerated pathology observed in arteries of children with sickle cell disease.

References

  1. Annu Rev Biomed Eng. 2010 Aug 15;12:345-67 - PubMed
  2. Annu Rev Physiol. 1997;59:63-88 - PubMed
  3. Blood. 2008 Oct 15;112(8):3474-83 - PubMed
  4. Cardiovasc Res. 2004 Jun 1;62(3):610-20 - PubMed
  5. Am J Pathol. 2007 Mar;170(3):809-17 - PubMed
  6. Lancet Neurol. 2006 Jun;5(6):501-12 - PubMed
  7. Rev Mal Respir. 2011 Feb;28(2):129-37 - PubMed
  8. J Clin Invest. 1999 Nov;104(9):1191-7 - PubMed
  9. Am J Physiol Heart Circ Physiol. 2007 Mar;292(3):H1479-86 - PubMed
  10. Blood. 2000 Oct 1;96(7):2451-9 - PubMed
  11. Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1784-90 - PubMed
  12. Biochem J. 1998 May 1;331 ( Pt 3):727-32 - PubMed
  13. Ann Hematol. 2007 Apr;86(4):255-61 - PubMed
  14. Arch Biochem Biophys. 2011 Dec 1;516(1):52-7 - PubMed
  15. Am J Physiol Heart Circ Physiol. 2005 Jun;288(6):H2715-25 - PubMed
  16. Atherosclerosis. 2006 Feb;184(2):302-11 - PubMed
  17. Blood. 2009 Dec 10;114(25):5117-25 - PubMed
  18. Blood. 1987 Jul;70(1):152-7 - PubMed
  19. Anal Biochem. 2010 Jun 1;401(1):91-8 - PubMed
  20. Biochemistry. 1999 Feb 23;38(8):2377-85 - PubMed
  21. J Transl Med. 2011 Jul 14;9:109 - PubMed
  22. Nat Cell Biol. 2007 Aug;9(8):970-7 - PubMed
  23. Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1119-27 - PubMed
  24. J Biol Chem. 1998 Nov 27;273(48):32347-52 - PubMed
  25. J Clin Invest. 1998 Aug 1;102(3):576-83 - PubMed
  26. J Biol Chem. 2004 Aug 27;279(35):36761-70 - PubMed
  27. JAMA. 1999 Dec 1;282(21):2035-42 - PubMed
  28. J Clin Invest. 2003 Aug;112(4):517-26 - PubMed

Publication Types

Grant support